0001447362-24-000106.txt : 20240703 0001447362-24-000106.hdr.sgml : 20240703 20240703161541 ACCESSION NUMBER: 0001447362-24-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240703 DATE AS OF CHANGE: 20240703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oelschlager Kristen M CENTRAL INDEX KEY: 0001856565 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38984 FILM NUMBER: 241100319 MAIL ADDRESS: STREET 1: C/O CASTLE BIOSCIENCES STREET 2: 505 S. FRIENDSWOOD DRIVE, SUITE 401 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC CENTRAL INDEX KEY: 0001447362 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 770701774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 S FRIENDSWOOD DRIVE STREET 2: SUITE 401 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 BUSINESS PHONE: 866-788-9007 MAIL ADDRESS: STREET 1: 505 S FRIENDSWOOD DRIVE STREET 2: SUITE 401 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 4 1 wk-form4_1720037734.xml FORM 4 X0508 4 2024-07-01 0 0001447362 CASTLE BIOSCIENCES INC CSTL 0001856565 Oelschlager Kristen M C/O CASTLE BIOSCIENCES, INC. 505 S FRIENDSWOOD DRIVE, SUITE 401 FRIENDSWOOD TX 77546 0 1 0 0 Chief Operating Officer 1 Common Stock 2024-07-01 4 S 0 2793 21.224 D 148618 D The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Kristen Oelschlager on March 15, 2024. This transaction was executed in multiple trades at prices ranging from $20.890 to $21.705, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 1,109 shares acquired on February 29, 2024, under the Issuer's employee stock purchase plan. /s/ Frank Stokes, Attorney-in-fact 2024-07-03